Market Analysis and Insights: Global Nanobiotechnology Market
Nanobiotechnology is a veritable tool for the advancement of medical science, which will help improve healthcare practices across the world. This is because nanobiotechnology is the key for studying minute biological samples as small as a single molecule. The use of several nanoparticles and nanodevices for studying small biological samples are expected to benefit human health enormously. The use of nanobiotechnology is expected to extend opportunities and enhance the capabilities of other areas such as forensic science and forensic diagnostics.
The global Nanobiotechnology market size is projected to reach US$ 103260 million by 2028, from US$ 67230 million in 2021, at a CAGR of 6.2% during 2022-2028.
Fully considering the economic change by this health crisis, Nanomedicine accounting for % of the Nanobiotechnology global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Anticancer segment is altered to an % CAGR throughout this forecast period.
China Nanobiotechnology market size is valued at US$ million in 2021, while the North America and Europe Nanobiotechnology are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Nanobiotechnology landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nanobiotechnology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nanobiotechnology market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nanobiotechnology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nanobiotechnology market.
Global Nanobiotechnology Scope and Market Size
Nanobiotechnology market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Nanobiotechnology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Segment by Application
Anticancer
CNS Product
Anti-infective
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International